Guardian Pharmacy Services, Inc. GRDN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 371.07M | 351.77M | 336.60M | 397.62M | 377.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 371.07M | 351.77M | 336.60M | 397.62M | 377.43M |
| Cost of Revenue | 285.85M | 271.72M | 260.29M | 312.11M | 302.71M |
| Gross Profit | 85.22M | 80.04M | 76.31M | 85.50M | 74.72M |
| SG&A Expenses | 60.14M | 67.80M | 55.43M | 50.14M | 57.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 345.99M | 339.53M | 315.72M | 362.25M | 360.60M |
| Operating Income | 25.09M | 12.24M | 20.88M | 35.37M | 16.83M |
| Income Before Tax | 25.98M | 29.79M | 18.29M | 31.10M | 16.63M |
| Income Tax Expenses | 6.86M | 7.67M | 4.75M | 9.83M | 7.04M |
| Earnings from Continuing Operations | 19.12M | 22.12M | 13.54M | 21.27M | 9.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -440.00K | -249.00K | -249.00K | -342.00K | 225.00K |
| Net Income | 18.68M | 21.87M | 13.30M | 20.92M | 9.82M |
| EBIT | 25.09M | 12.24M | 20.88M | 35.37M | 16.83M |
| EBITDA | 31.02M | 18.05M | 26.85M | 41.11M | 22.67M |
| EPS Basic | 0.29 | 0.35 | 0.21 | 0.33 | 0.16 |
| Normalized Basic EPS | 0.25 | 0.21 | 0.21 | 0.35 | 0.18 |
| EPS Diluted | 0.29 | 0.34 | 0.21 | 0.33 | 0.15 |
| Normalized Diluted EPS | 0.25 | 0.21 | 0.21 | 0.35 | 0.17 |
| Average Basic Shares Outstanding | 63.34M | 63.33M | 63.32M | 63.32M | 62.12M |
| Average Diluted Shares Outstanding | 63.92M | 63.84M | 63.69M | 63.62M | 63.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |